Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues.
Ben-Ami
Ronen
R
Paran
Daphna
D
Herishanu
Yair
Y
Elkayam
Ori
O
Shopin
Ludmila
L
D000283:Administration, Intravesical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous